Hear first-hand two local CFOs’ views on relationship building – including their relationship with an IRO. 

IROs know they need to excel at crafting corporate messages, communicating and telling our company’s story to various stakeholder audiences. A key factor to our success is our ability to nurture and develop relationships with others, both inside and outside of your organization. And CFOs can offer a wealth of advice on how best to do it.

We’ll take this meeting as an opportunity to examine relationship building at its best. Are you giving the C-Suite all the facts they need to make an informed decision? Do you anticipate their follow-up questions? Are you as aware as leadership is of the company’s business needs and goals? Do your business leaders quickly respond to your requests for information because of their relationship with you? Are you connected, regularly speaking to the buy-side, sell-side and prospects? Do you spend as much time as you should outside the office, going on roadshows, attending conferences or industry functions? Do you also take time to visit manufacturing sites/offices and talk to Board members?

Bring your questions, as our CFOs share their insights for a discussion on:

• Establishing credibility;
• Building Your network;
• Understanding business needs and goals;
• Delivering results; and
• Providing exceptional service. 

Register yourself and bring along your finance, communications, marketing, and IR colleagues. For more details on the event and the panelists, please visit www.niriphiladelphia.org.

Speakers: 

Barry Niziolek is Executive Vice President and Chief Financial Officer of Trinseo (NYSE: TSE), a $4 billion global materials solution provider and manufacturer of plastics, latex binder and synthetic rubber with manufacturing sites in 19 countries. Previously, Niziolek was Vice President and Controller at DuPont, where he had extensive experience in finance leadership, governance and compliance, board interactions, mergers and acquisitions, risk management, corporate planning, new business development, and investor relations.

During his 34 years at DuPont, Niziolek held a wide range of Finance roles, including CFO for the titanium dioxide and coatings businesses, as well as CFO for the crop protection business. He also served as CFO for DuPont’s Mexico operations, where he was based in Mexico City. Other DuPont assignments included investor relations, information systems, business analysis and accounting. He began his career at KPMG as a Senior Auditor.

Niziolek holds a Master of Business Administration from the University of Delaware and a Bachelor’s degree in Accounting from Wilkes University. He is a Certified Public Accountant.

Gary Sender is Chief Financial Officer of Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections. He has more than 25 years of financial leadership experience in the pharmaceutical and biopharmaceutical industries, most recently as Chief Financial Officer and EVP at Synergy Pharmaceuticals.

From 2009 to 2015, Mr. Sender served as Senior Vice President, Finance at Shire PLC, supporting its Specialty Pharmaceuticals business and subsequently its Global Commercial businesses. He was responsible for financial management and support of all commercial areas of Shire’s $6 billion Specialty Pharmaceutical and Rare Disease businesses, with an emphasis on resource allocation, financial forecasting, business cases and M&A. Prior to joining Shire, he was the founding CFO of Tengion – a biotechnology company in the field of Regenerative Medicine.

Mr. Sender spent 15 years in a number of leadership roles within Merck, including Investor Relations, M&A Finance, Treasury and Divisional Financial Management. Mr. Sender holds a bachelor’s degree in Finance and Information Systems from Boston University and a master’s degree in Industrial Administration (MBA) with a concentration in Finance from Carnegie-Mellon University.